Rock Creek Pharmaceuticals Announces the Addition of Key Opinion Leaders to Enhance Dermatological Disease Program

Published on January 6, 2025

but not limited to, failure to obtain sufficient capital resources to fund our development program and operations, results of clinical

Continue reading on website
Other news

Earnings Preview: What To Expect From Norfolk Southern's Report

January 6, 2025
S&P 500 Index’s ( $SPX ) 26.3% surge and the Industrial Select Sector SPDR Fund’s ( XLI ) 19.4% returns during the same time frame.Norfolk

Rock Creek Pharmaceuticals Announces Interim Amendments to Convertible Notes and Update on Financing Options

January 6, 2025
science focused investment advisory organization, on a best efforts basis, to assist in providing additional potential financing options